CAPPED BONUSZERTIFIKAT - STRYKER CORP. Share Price

Certificat

DE000PC5RTZ8

Market Closed - Boerse Frankfurt Warrants 20:40:11 10/05/2024 BST
320 EUR +0.52% Intraday chart for CAPPED BONUSZERTIFIKAT - STRYKER CORP.
Current month-0.11%
1 month+0.09%
Date Price Change Volume
10/05/24 319 +0.23% 0
09/05/24 318.3 +0.16% 0
08/05/24 317.8 -0.29% 0
07/05/24 318.7 +1.04% 0
06/05/24 315.5 -0.25% 0

Real-time Boerse Frankfurt Warrants

Last update May 10, 2024 at 08:40 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5RTZ
ISINDE000PC5RTZ8
Date issued 27/02/2024
Strike 360 $
Maturity 20/09/2024 (132 Days)
Parity 1 : 1
Emission price 310.9
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 321.4
Lowest since issue 310.7
Spread 0.5
Spread %0.16%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus